Tempest Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
17.67
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.80
|
-0.66
|
0.14
|
17.50%
|
|
2022-06-30
|
-0.92
|
-0.79
|
0.13
|
14.13%
|
|
2022-03-31
|
-1.12
|
-1.18
|
-0.06
|
-5.36%
|
|
2021-12-31
|
-1.23
|
-1.12
|
0.11
|
8.94%
|
|
2021-09-30
|
-1.05
|
-1.21
|
-0.16
|
-15.24%
|
|
2021-06-30
|
-0.87
|
-7.63
|
-6.76
|
-777.01%
|
|
2021-03-31
|
-5.25
|
-6.60
|
-1.35
|
-25.71%
|
|
2020-12-31
|
-5.15
|
-5.85
|
-0.70
|
-13.59%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.63
|
|
2021-12-31
|
-16.56
|
|
2020-12-31
|
-29.10
|
|
2019-12-31
|
-37.98
|
|
2018-12-31
|
-8.06
|
|
2017-12-31
|
-21.45
|
|
2016-12-31
|
-9.31
|
|
2015-12-31
|
-2.71
|
|
2014-12-31
|
-13.78
|
|
2013-12-31
|
-22.65
|
|
2012-12-31
|
-99.27
|